Susceptibility of Microorganisms Isolated from Chronic Suppurative Otitis Media to Ciprofloxacin

Overview

Journal Eur Arch Otorhinolaryngol

Specialty Otorhinolaryngology

Date 1996 Jan 1

PMID 8858262

Citations 2

Authors

A Altuntas

A Aslan

N Eren

A Unal

Y Nalca

Affiliations

Soon will be listed here.

Abstract

In order to evaluate the susceptibility of the microorganisms isolated from chronic suppurative otitis media to ciprofloxacin, cultures of specimens from 127 patients with chronic suppurative otitis media and their antibiotic sensitivity results were examined. The most common aerobic isolates were Pseudomonas sp., Proteus sp., and Staphylococcus aureus with recovery rates of 40.7%, 21.6% and 19.1% respectively. Sensitivity results showed that 6.2% of Pseudomonas isolates, 2.9% of Proteus isolates, 10% of Staphylococcus aureus isolates and 8.3% of Escherichia coli isolates were resistant to ciprofloxacin.

Citing Articles

The investigation of bacteriology of chronic suppurative otitis media in patients attending a tertiary care hospital with special emphasis on seasonal variation.

Maji P, Chatterjee T, Chatterjee S, Chakrabarty J, Mukhopadhyay B Indian J Otolaryngol Head Neck Surg. 2012; 59(2):128-31.

PMID: 23120410 PMC: 3451782. DOI: 10.1007/s12070-007-0038-x.

Quinolone ear drops for chronic otitis media. They are safer and more effective than aminoglycosides.

Ghosh S, Panarese A, Parker A, Bull P BMJ. 2000; 321(7254):126-7.

PMID: 10894673 PMC: 1118144. DOI: 10.1136/bmj.321.7254.126.

References

Piccirillo J, Parnes S . Ciprofloxacin for the treatment of chronic ear disease. Laryngoscope. 1989; 99(5):510-3. DOI: 10.1288/00005537-198905000-00009. View

Esposito S, Noviello S, dErrico G, Montanaro C . Topical ciprofloxacin vs intramuscular gentamicin for chronic otitis media. Arch Otolaryngol Head Neck Surg. 1992; 118(8):842-4. DOI: 10.1001/archotol.1992.01880080064014. View

Nakagawa T, Yadohisa O, Komune S, Uemura T . A 16-year survey of changes in bacterial isolates associated with chronic suppurative otitis media. Eur Arch Otorhinolaryngol. 1994; 251 Suppl 1:S27-32. DOI: 10.1007/BF02565215. View

Brook I . The role of anaerobic bacteria in otitis media: microbiology, pathogenesis, and implications on therapy. Am J Otolaryngol. 1987; 8(2):109-17. DOI: 10.1016/s0196-0709(87)80033-9. View

Giamarellou H, Galanakis N, Dendrinos C, Stefanou J, Daphnis E, Daikos G . Evaluation of ciprofloxacin in the treatment of Pseudomonas aeruginosa infections. Eur J Clin Microbiol. 1986; 5(2):232-5. DOI: 10.1007/BF02013996. View

Erkan M, Aslan T, Sevuk E, Guney E . Bacteriology of chronic suppurative otitis media. Ann Otol Rhinol Laryngol. 1994; 103(10):771-4. DOI: 10.1177/000348949410301005. View

Danisovicova A, BREZINA M, Belan S, Kayserova H, Kaiserova E, Hruskovic I . Magnetic resonance imaging in children receiving quinolones: no evidence of quinolone-induced arthropathy. A multicenter survey. Chemotherapy. 1994; 40(3):209-14. DOI: 10.1159/000239194. View

Buirma R, Horrevorts A, Wagenvoort J . Incidence of multi-resistant gram-negative isolates in eight Dutch hospitals. The 1990 Dutch Surveillance Study. Scand J Infect Dis Suppl. 1991; 78:35-44. View

Papastavros T, Giamarellou H, Varlejides S . Role of aerobic and anaerobic microorganisms in chronic suppurative otitis media. Laryngoscope. 1986; 96(4):438-42. DOI: 10.1288/00005537-198604000-00017. View

10.

Claes J, Govaerts P, Van de Heyning P, Peeters S . Lack of ciprofloxacin ototoxicity after repeated ototopical application. Antimicrob Agents Chemother. 1991; 35(5):1014-6. PMC: 245150. DOI: 10.1128/AAC.35.5.1014. View

11.

Dornbusch K . Resistance to beta-lactam antibiotics and ciprofloxacin in gram-negative bacilli and staphylococci isolated from blood: a European collaborative study. European Study Group on Antibiotic Resistance. J Antimicrob Chemother. 1990; 26(2):269-78. DOI: 10.1093/jac/26.2.269. View

12.

Esposito S, dErrico G, Montanaro C . Topical and oral treatment of chronic otitis media with ciprofloxacin. A preliminary study. Arch Otolaryngol Head Neck Surg. 1990; 116(5):557-9. DOI: 10.1001/archotol.1990.01870050057006. View

13.

Chysky V, Kapila K, Hullmann R, ARCIERI G, Schacht P, Echols R . Safety of ciprofloxacin in children: worldwide clinical experience based on compassionate use. Emphasis on joint evaluation. Infection. 1991; 19(4):289-96. DOI: 10.1007/BF01644970. View

14.

Brook I, Yocum P . Quantitative bacterial cultures and beta-lactamase activity in chronic suppurative otitis media. Ann Otol Rhinol Laryngol. 1989; 98(4 Pt 1):293-7. DOI: 10.1177/000348948909800411. View

15.

Chiodo A, Alberti P . Experimental, clinical and preventive aspects of ototoxicity. Eur Arch Otorhinolaryngol. 1994; 251(7):375-92. DOI: 10.1007/BF00181963. View

16.

Scully B, Neu H, Parry M, MANDELL W . Oral ciprofloxacin therapy of infections due to Pseudomonas aeruginosa. Lancet. 1986; 1(8485):819-22. DOI: 10.1016/s0140-6736(86)90937-2. View

17.

Karma P, Jokippi L, Ojala K, Jokipii A . Bacteriology of the chronically discharging middle ear. Acta Otolaryngol. 1978; 86(1-2):110-4. DOI: 10.3109/00016487809124726. View

18.

Papastavros T, Giamarellou H, Varlejides S . Preoperative therapeutic considerations in chronic suppurative otitis media. Laryngoscope. 1989; 99(6 Pt 1):655-9. DOI: 10.1288/00005537-198906000-00016. View

19.

Shalit I, Haas H, Berger S . Susceptibility of Pseudomonas aeruginosa to fluoroquinolones following four years of use in a tertiary care hospital. J Antimicrob Chemother. 1992; 30(2):149-52. DOI: 10.1093/jac/30.2.149. View

20.

MacGowan A, Brown N, HOLT H, Lovering A, McCulloch S, Reeves D . An eight-year survey of the antimicrobial susceptibility patterns of 85,971 bacteria isolated from patients in a district general hospital and the local community. J Antimicrob Chemother. 1993; 31(4):543-57. DOI: 10.1093/jac/31.4.543. View